Clinical trial · Observational
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
Molecular Detection of Circulating Cancer Cells in Breast, Ovarian, Colon and Pancreatic Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Due to poor accrual
Summary
Brief summary (as posted)
RATIONALE: Counting the number of circulating cancer cells in samples of blood from patients with metastatic cancer may help doctors find out how much the cancer has spread. PURPOSE: This research study is looking at the number of circulating cancer cells in patients with metastatic breast cancer, ovarian cancer, colon cancer, or pancreatic cancer.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (6)
- label
- Metastatic Breast Cancer
- label
- Metastatic Ovarian Cancer
- label
- Metastatic Pancreatic Cancer
- label
- Metastatic Colon Cancer
- label
- Stage 3 Ovarian Cancer
- label
- Locally Advanced Pancreatic Cancer
Primary outcomes (3)
- measure
- Frequency of circulating cancer cells (CTC)
- timeFrame
- 1 day
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Radiographic or marker evidence of metastatic ovarian, breast, pancreatic, or colon disease * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * No history of any prior cancer PRIOR CONCURRENT THERAPY: * No prior therapy for metastatic disease
References
Publications (0)
Data not yet available